BCAX
Price
$28.15
Change
-$0.76 (-2.63%)
Updated
Jul 13 closing price
Capitalization
1.85B
36 days until earnings call
Intraday BUY SELL Signals
IMMX
Price
$10.52
Change
-$0.59 (-5.31%)
Updated
Jul 13 closing price
Capitalization
748.92M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs IMMX

BCAX vs IMMX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BCAX vs. IMMX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a StrongBuy and IMMX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (BCAX: $28.91 vs. IMMX: $10.52)
Brand notoriety: BCAX and IMMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 44% vs. IMMX: 39%
Market capitalization -- BCAX: $1.85B vs. IMMX: $748.92M
BCAX [@Biotechnology] is valued at $1.85B. IMMX’s [@Biotechnology] market capitalization is $748.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileIMMX’s FA Score has 0 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • IMMX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAX is a better buy in the long-term than IMMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 6 TA indicator(s) are bullish while IMMX’s TA Score has 6 bullish TA indicator(s).

  • BCAX’s TA Score: 6 bullish, 3 bearish.
  • IMMX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both BCAX and IMMX are a good buy in the short-term.

Price Growth

BCAX (@Biotechnology) experienced а -0.31% price change this week, while IMMX (@Biotechnology) price change was +0.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.13%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +1806.57%.

Reported Earning Dates

BCAX is expected to report earnings on Aug 18, 2026.

IMMX is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Biotechnology (-3.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCAX($1.85B) has a higher market cap than IMMX($749M). IMMX YTD gains are higher at: 101.147 vs. BCAX (67.261). IMMX has higher annual earnings (EBITDA): -35.64M vs. BCAX (-173.93M). BCAX has more cash in the bank: 540M vs. IMMX (90.6M). IMMX has less debt than BCAX: IMMX (1.04M) vs BCAX (1.44M). BCAX (0) and IMMX (0) have equivalent revenues.
BCAXIMMXBCAX / IMMX
Capitalization1.85B749M247%
EBITDA-173.93M-35.64M488%
Gain YTD67.261101.14766%
P/E Ratio3.41N/A-
Revenue00-
Total Cash540M90.6M596%
Total Debt1.44M1.04M139%
TECHNICAL ANALYSIS
Technical Analysis
BCAXIMMX
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
IMMX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WSML34.82N/A
N/A
iShares MSCI World Small-Cap ETF
PBAP31.07-0.06
-0.20%
PGIM S&P 500 Buffer 20 ETF - Apr
JHCR25.00-0.12
-0.48%
JHancock Core Bond ETF
GOOY13.06-0.10
-0.76%
YieldMax GOOGL Option Income Stgy ETF
TNA69.71-1.80
-2.52%
Direxion Daily Small Cap Bull 3X ETF

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with CLDX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-2.63%
CLDX - BCAX
48%
Loosely correlated
-1.48%
PCVX - BCAX
47%
Loosely correlated
-2.03%
BCYC - BCAX
45%
Loosely correlated
-1.36%
NRIX - BCAX
44%
Loosely correlated
-1.52%
RCUS - BCAX
44%
Loosely correlated
-2.94%
More